| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroidectomy | 12 | 2016 | 489 | 1.230 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2022 | 7783 | 0.880 |
Why?
|
| Image Enhancement | 4 | 2017 | 553 | 0.780 |
Why?
|
| Skin Aging | 1 | 2020 | 24 | 0.700 |
Why?
|
| Cosmetic Techniques | 1 | 2020 | 23 | 0.680 |
Why?
|
| Social Class | 1 | 2021 | 324 | 0.670 |
Why?
|
| Ossification, Heterotopic | 1 | 2019 | 70 | 0.650 |
Why?
|
| Contrast Media | 8 | 2022 | 1499 | 0.640 |
Why?
|
| Gadolinium DTPA | 2 | 2017 | 173 | 0.640 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2021 | 340 | 0.630 |
Why?
|
| Sphenoid Sinus | 1 | 2017 | 23 | 0.580 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2017 | 19 | 0.580 |
Why?
|
| Thyroid Nodule | 6 | 2016 | 92 | 0.550 |
Why?
|
| Mastoiditis | 1 | 2016 | 32 | 0.530 |
Why?
|
| Radiology Information Systems | 1 | 2017 | 119 | 0.530 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2016 | 55 | 0.520 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2020 | 7895 | 0.510 |
Why?
|
| Thyroid Neoplasms | 9 | 2016 | 1894 | 0.490 |
Why?
|
| Colonic Diseases | 3 | 2013 | 70 | 0.460 |
Why?
|
| Cholesterol | 1 | 2017 | 659 | 0.460 |
Why?
|
| Recurrent Laryngeal Nerve | 4 | 2016 | 16 | 0.450 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2014 | 93 | 0.430 |
Why?
|
| Thyroid Gland | 5 | 2016 | 366 | 0.430 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 2027 | 0.400 |
Why?
|
| Hoarseness | 1 | 2011 | 26 | 0.390 |
Why?
|
| Tracheal Diseases | 1 | 2011 | 36 | 0.380 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2014 | 334 | 0.380 |
Why?
|
| Tomography, Spiral Computed | 2 | 2008 | 128 | 0.360 |
Why?
|
| Hepatic Veins | 1 | 2010 | 59 | 0.350 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 761 | 0.350 |
Why?
|
| Liver Neoplasms | 4 | 2020 | 4821 | 0.340 |
Why?
|
| Amyloidosis | 1 | 2011 | 173 | 0.340 |
Why?
|
| Robotics | 5 | 2014 | 365 | 0.340 |
Why?
|
| Thyroid Diseases | 1 | 2010 | 85 | 0.340 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 218 | 0.330 |
Why?
|
| Monitoring, Intraoperative | 4 | 2015 | 264 | 0.330 |
Why?
|
| Hepatic Artery | 1 | 2010 | 255 | 0.330 |
Why?
|
| Iohexol | 5 | 2014 | 56 | 0.320 |
Why?
|
| Colonography, Computed Tomographic | 4 | 2011 | 55 | 0.320 |
Why?
|
| Airway Obstruction | 1 | 2011 | 273 | 0.310 |
Why?
|
| Dyspnea | 1 | 2011 | 420 | 0.310 |
Why?
|
| Liver Cirrhosis | 5 | 2014 | 1046 | 0.290 |
Why?
|
| Diagnosis, Differential | 8 | 2019 | 4831 | 0.290 |
Why?
|
| Humans | 66 | 2022 | 270740 | 0.250 |
Why?
|
| Electromyography | 2 | 2016 | 230 | 0.250 |
Why?
|
| Middle Aged | 34 | 2021 | 90352 | 0.240 |
Why?
|
| Postoperative Complications | 8 | 2019 | 5681 | 0.240 |
Why?
|
| Colon | 1 | 2008 | 659 | 0.230 |
Why?
|
| Male | 38 | 2021 | 128315 | 0.210 |
Why?
|
| Shigella | 1 | 2022 | 5 | 0.200 |
Why?
|
| Dysentery, Bacillary | 1 | 2022 | 10 | 0.200 |
Why?
|
| Staphylococcus aureus | 3 | 2020 | 562 | 0.200 |
Why?
|
| Retrospective Studies | 21 | 2021 | 39890 | 0.200 |
Why?
|
| Osteosarcoma | 2 | 2019 | 950 | 0.200 |
Why?
|
| Radiographic Image Enhancement | 3 | 2017 | 410 | 0.200 |
Why?
|
| Vocal Cord Paralysis | 2 | 2015 | 95 | 0.200 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2022 | 430 | 0.190 |
Why?
|
| Encephalocele | 1 | 2021 | 59 | 0.190 |
Why?
|
| Neonatal Sepsis | 1 | 2021 | 29 | 0.190 |
Why?
|
| Adult | 27 | 2021 | 82040 | 0.190 |
Why?
|
| Diagnostic Imaging | 4 | 2020 | 1174 | 0.180 |
Why?
|
| Biopsy, Fine-Needle | 4 | 2016 | 689 | 0.180 |
Why?
|
| Dominican Republic | 1 | 2020 | 19 | 0.180 |
Why?
|
| Switzerland | 1 | 2020 | 25 | 0.180 |
Why?
|
| Ireland | 1 | 2020 | 31 | 0.180 |
Why?
|
| Rejuvenation | 1 | 2020 | 23 | 0.180 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2021 | 170 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 4 | 2022 | 3187 | 0.170 |
Why?
|
| Adenocarcinoma, Follicular | 2 | 2012 | 131 | 0.170 |
Why?
|
| Fractures, Avulsion | 1 | 2019 | 5 | 0.170 |
Why?
|
| Tendinopathy | 1 | 2019 | 15 | 0.170 |
Why?
|
| Myositis Ossificans | 1 | 2019 | 17 | 0.170 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2019 | 38 | 0.170 |
Why?
|
| Dermatofibrosarcoma | 1 | 2020 | 73 | 0.170 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2019 | 38 | 0.170 |
Why?
|
| Chondrocalcinosis | 1 | 2019 | 26 | 0.170 |
Why?
|
| Musculoskeletal System | 1 | 2019 | 37 | 0.170 |
Why?
|
| Female | 39 | 2021 | 148940 | 0.170 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2019 | 33 | 0.170 |
Why?
|
| Australia | 1 | 2020 | 259 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 417 | 0.160 |
Why?
|
| Sarcopenia | 1 | 2020 | 114 | 0.160 |
Why?
|
| Chemotherapy-Induced Febrile Neutropenia | 1 | 2018 | 33 | 0.160 |
Why?
|
| China | 1 | 2020 | 636 | 0.150 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 291 | 0.150 |
Why?
|
| SEER Program | 1 | 2021 | 1047 | 0.140 |
Why?
|
| Biopsy | 2 | 2017 | 3484 | 0.140 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 1 | 2016 | 21 | 0.140 |
Why?
|
| Gout | 1 | 2019 | 146 | 0.140 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2016 | 33 | 0.140 |
Why?
|
| Calcinosis | 1 | 2019 | 426 | 0.130 |
Why?
|
| Radiography | 2 | 2019 | 1986 | 0.130 |
Why?
|
| Colorectal Neoplasms | 2 | 2010 | 3707 | 0.130 |
Why?
|
| Cross Infection | 1 | 2020 | 550 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2021 | 602 | 0.130 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 437 | 0.130 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2018 | 770 | 0.120 |
Why?
|
| Aged, 80 and over | 11 | 2021 | 30998 | 0.120 |
Why?
|
| Aged | 21 | 2021 | 73333 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 2020 | 678 | 0.120 |
Why?
|
| Diatrizoate | 1 | 2014 | 12 | 0.120 |
Why?
|
| Pancreatic Diseases | 1 | 2015 | 113 | 0.120 |
Why?
|
| Liver | 3 | 2017 | 3086 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 917 | 0.120 |
Why?
|
| Diatrizoate Meglumine | 1 | 2014 | 22 | 0.120 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 633 | 0.120 |
Why?
|
| Free Tissue Flaps | 1 | 2019 | 374 | 0.110 |
Why?
|
| Pakistan | 3 | 2022 | 81 | 0.110 |
Why?
|
| Cathartics | 2 | 2011 | 40 | 0.110 |
Why?
|
| alpha-Defensins | 1 | 2013 | 15 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 2 | 2019 | 4147 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2013 | 136 | 0.110 |
Why?
|
| Neck | 1 | 2016 | 395 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2020 | 2175 | 0.110 |
Why?
|
| Chromogranin A | 1 | 2013 | 67 | 0.110 |
Why?
|
| Exotoxins | 1 | 2013 | 76 | 0.110 |
Why?
|
| Acute Disease | 2 | 2016 | 2493 | 0.110 |
Why?
|
| Treatment Outcome | 11 | 2020 | 33737 | 0.100 |
Why?
|
| Cholangiography | 1 | 2012 | 34 | 0.100 |
Why?
|
| Goiter | 1 | 2012 | 17 | 0.100 |
Why?
|
| Laryngoscopy | 2 | 2011 | 199 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 424 | 0.100 |
Why?
|
| Endoscopy | 2 | 2012 | 496 | 0.100 |
Why?
|
| Biliary Tract Diseases | 1 | 2012 | 65 | 0.100 |
Why?
|
| Neoplasm Staging | 4 | 2021 | 14012 | 0.100 |
Why?
|
| Pancreas | 1 | 2015 | 744 | 0.100 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 262 | 0.100 |
Why?
|
| Cholecystectomy | 1 | 2012 | 118 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 6256 | 0.100 |
Why?
|
| Laryngeal Nerves | 1 | 2011 | 8 | 0.100 |
Why?
|
| Laryngeal Muscles | 1 | 2011 | 14 | 0.100 |
Why?
|
| Citric Acid | 1 | 2011 | 53 | 0.090 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2011 | 3 | 0.090 |
Why?
|
| Ciliary Motility Disorders | 1 | 2011 | 14 | 0.090 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2012 | 509 | 0.090 |
Why?
|
| Colectomy | 1 | 2013 | 292 | 0.090 |
Why?
|
| Carcinoma, Papillary | 2 | 2016 | 566 | 0.090 |
Why?
|
| Triiodobenzoic Acids | 1 | 2011 | 69 | 0.090 |
Why?
|
| Rescue Work | 2 | 2011 | 11 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 5162 | 0.090 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2010 | 7 | 0.090 |
Why?
|
| Goiter, Substernal | 1 | 2010 | 2 | 0.090 |
Why?
|
| Goiter, Nodular | 1 | 2010 | 6 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2018 | 2441 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 209 | 0.090 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2015 | 527 | 0.090 |
Why?
|
| Feasibility Studies | 4 | 2022 | 2353 | 0.080 |
Why?
|
| Time Factors | 8 | 2016 | 13006 | 0.080 |
Why?
|
| Proteome | 1 | 2013 | 571 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 2019 | 2665 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 466 | 0.080 |
Why?
|
| Trachea | 1 | 2011 | 298 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2014 | 6224 | 0.080 |
Why?
|
| Survival Rate | 2 | 2021 | 12541 | 0.080 |
Why?
|
| Neutrophils | 1 | 2013 | 873 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2015 | 1567 | 0.080 |
Why?
|
| Surgical Flaps | 3 | 2004 | 894 | 0.080 |
Why?
|
| Ascites | 1 | 2009 | 213 | 0.080 |
Why?
|
| Prognosis | 5 | 2020 | 22505 | 0.080 |
Why?
|
| Hospitals, Veterans | 1 | 2010 | 371 | 0.080 |
Why?
|
| Incidental Findings | 1 | 2010 | 282 | 0.080 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 656 | 0.080 |
Why?
|
| United States | 3 | 2021 | 15861 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2013 | 1309 | 0.070 |
Why?
|
| Robotic Surgical Procedures | 1 | 2014 | 533 | 0.070 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 4492 | 0.070 |
Why?
|
| Peptides | 1 | 2013 | 1504 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 654 | 0.070 |
Why?
|
| Organoplatinum Compounds | 1 | 2010 | 704 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2021 | 1076 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2007 | 120 | 0.070 |
Why?
|
| Neoplasms, Second Primary | 1 | 2015 | 1388 | 0.070 |
Why?
|
| Terrorism | 1 | 2006 | 6 | 0.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2010 | 347 | 0.070 |
Why?
|
| Blast Injuries | 1 | 2006 | 51 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 2020 | 4895 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2011 | 694 | 0.060 |
Why?
|
| Electrophysiological Phenomena | 2 | 2016 | 93 | 0.060 |
Why?
|
| Apoptosis | 1 | 2019 | 7757 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2016 | 3077 | 0.060 |
Why?
|
| Colonic Polyps | 1 | 2007 | 228 | 0.060 |
Why?
|
| Embolization, Therapeutic | 1 | 2010 | 605 | 0.060 |
Why?
|
| Sesamoid Bones | 1 | 2004 | 2 | 0.060 |
Why?
|
| Thumb | 1 | 2004 | 41 | 0.060 |
Why?
|
| Arthritis, Psoriatic | 1 | 2004 | 30 | 0.060 |
Why?
|
| Triage | 1 | 2006 | 255 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2008 | 1690 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 585 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 9042 | 0.060 |
Why?
|
| Foot Injuries | 1 | 2003 | 12 | 0.050 |
Why?
|
| Psoriasis | 1 | 2004 | 143 | 0.050 |
Why?
|
| Mandibular Neoplasms | 1 | 2004 | 77 | 0.050 |
Why?
|
| Lip Neoplasms | 1 | 2003 | 20 | 0.050 |
Why?
|
| Lip | 1 | 2003 | 35 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 10400 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2007 | 425 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 5866 | 0.050 |
Why?
|
| Soft Tissue Injuries | 1 | 2003 | 48 | 0.050 |
Why?
|
| Operative Time | 2 | 2014 | 255 | 0.050 |
Why?
|
| Kidney | 1 | 2011 | 2121 | 0.050 |
Why?
|
| Lymph Node Excision | 3 | 2016 | 2062 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 4958 | 0.050 |
Why?
|
| Cranial Fossa, Middle | 1 | 2021 | 6 | 0.050 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2022 | 127 | 0.050 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2021 | 59 | 0.050 |
Why?
|
| Gram-Negative Bacteria | 1 | 2021 | 107 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2006 | 470 | 0.050 |
Why?
|
| Software | 1 | 2007 | 1355 | 0.040 |
Why?
|
| Disease Progression | 1 | 2011 | 6867 | 0.040 |
Why?
|
| Neuroendoscopy | 1 | 2019 | 35 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2016 | 2250 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2008 | 9292 | 0.040 |
Why?
|
| Mastectomy | 1 | 2005 | 1553 | 0.040 |
Why?
|
| Infant | 3 | 2022 | 13999 | 0.040 |
Why?
|
| Length of Stay | 2 | 2016 | 2007 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2016 | 13414 | 0.040 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 15218 | 0.040 |
Why?
|
| Vancomycin | 1 | 2020 | 292 | 0.040 |
Why?
|
| Mammaplasty | 1 | 2005 | 714 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2019 | 203 | 0.040 |
Why?
|
| Patient Care Planning | 1 | 2020 | 303 | 0.040 |
Why?
|
| Feces | 1 | 2022 | 861 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 867 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2022 | 1042 | 0.040 |
Why?
|
| Adolescent | 6 | 2016 | 32767 | 0.040 |
Why?
|
| Craniotomy | 1 | 2019 | 304 | 0.040 |
Why?
|
| Hospitals | 1 | 2020 | 484 | 0.040 |
Why?
|
| Vagus Nerve | 1 | 2016 | 70 | 0.030 |
Why?
|
| Algorithms | 1 | 2007 | 3891 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 6177 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 2016 | 127 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2016 | 51 | 0.030 |
Why?
|
| Reaction Time | 1 | 2016 | 233 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2016 | 125 | 0.030 |
Why?
|
| Observer Variation | 2 | 2008 | 709 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 15927 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 10708 | 0.030 |
Why?
|
| Young Adult | 4 | 2015 | 22251 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2020 | 1003 | 0.030 |
Why?
|
| Facial Muscles | 1 | 2014 | 46 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 76 | 0.030 |
Why?
|
| Prostate | 1 | 2020 | 1089 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 2394 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 2015 | 131 | 0.030 |
Why?
|
| Reoperation | 1 | 2019 | 1392 | 0.030 |
Why?
|
| Neurospora crassa | 1 | 2013 | 7 | 0.030 |
Why?
|
| Micrococcus luteus | 1 | 2013 | 3 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 7655 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2015 | 666 | 0.030 |
Why?
|
| Chromogranins | 1 | 2013 | 86 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 3063 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 206 | 0.030 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2014 | 172 | 0.030 |
Why?
|
| Aspergillus fumigatus | 1 | 2013 | 136 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 198 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2012 | 25 | 0.030 |
Why?
|
| Mitochondria | 1 | 2019 | 1297 | 0.030 |
Why?
|
| Decision Making | 1 | 2020 | 1252 | 0.030 |
Why?
|
| Gases | 1 | 2012 | 39 | 0.030 |
Why?
|
| Paraganglioma | 1 | 2014 | 200 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 354 | 0.020 |
Why?
|
| Breast | 1 | 2019 | 1369 | 0.020 |
Why?
|
| Candida | 1 | 2013 | 171 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2012 | 185 | 0.020 |
Why?
|
| Genes, ras | 1 | 2015 | 679 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 1267 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 590 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 54 | 0.020 |
Why?
|
| Clinical Decision-Making | 1 | 2015 | 533 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 75 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 303 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 387 | 0.020 |
Why?
|
| Contraindications | 1 | 2010 | 154 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2011 | 146 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 413 | 0.020 |
Why?
|
| Cilia | 1 | 2011 | 90 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 591 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2022 | 17061 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 984 | 0.020 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2012 | 261 | 0.020 |
Why?
|
| Sensory Receptor Cells | 1 | 2011 | 157 | 0.020 |
Why?
|
| Parathyroidectomy | 1 | 2011 | 211 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2016 | 1933 | 0.020 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2010 | 192 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 855 | 0.020 |
Why?
|
| Air Pollutants | 1 | 2011 | 135 | 0.020 |
Why?
|
| Creatinine | 1 | 2011 | 529 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 2357 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 313 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 2012 | 359 | 0.020 |
Why?
|
| Age Factors | 2 | 2011 | 5457 | 0.020 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2014 | 743 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8699 | 0.020 |
Why?
|
| Axilla | 1 | 2011 | 939 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 2315 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 5593 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 1571 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 1336 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 14617 | 0.020 |
Why?
|
| Parasympatholytics | 1 | 2007 | 12 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2453 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 2156 | 0.020 |
Why?
|
| Wound Healing | 1 | 2012 | 749 | 0.020 |
Why?
|
| Animals | 3 | 2020 | 61956 | 0.020 |
Why?
|
| Air | 1 | 2007 | 65 | 0.020 |
Why?
|
| Hypertension, Portal | 1 | 2008 | 129 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 4963 | 0.020 |
Why?
|
| Explosions | 1 | 2006 | 10 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 6764 | 0.020 |
Why?
|
| Posture | 1 | 2007 | 190 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2008 | 729 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 328 | 0.020 |
Why?
|
| Religion | 1 | 2006 | 95 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2006 | 246 | 0.020 |
Why?
|
| Carcinoma | 1 | 2016 | 2610 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 1248 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 14849 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2010 | 1015 | 0.010 |
Why?
|
| Developing Countries | 1 | 2006 | 349 | 0.010 |
Why?
|
| Heel | 1 | 2003 | 12 | 0.010 |
Why?
|
| Weight-Bearing | 1 | 2003 | 57 | 0.010 |
Why?
|
| Rats | 1 | 2012 | 6441 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 4372 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2004 | 112 | 0.010 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 12033 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 3444 | 0.010 |
Why?
|
| Rectal Neoplasms | 1 | 2010 | 1240 | 0.010 |
Why?
|
| Child | 2 | 2016 | 30559 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 12103 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 17888 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 16215 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2004 | 496 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 2184 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 7381 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2006 | 1255 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 15912 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2006 | 9470 | 0.010 |
Why?
|